CRISPRベースの診断の市場規模、シェア、動向分析レポート：製品別、技術別、用途別、最終用途別、地域別、セグメント予測、2025～2030年

CRISPRベースの診断市場の成長と動向

Grand View Research, Incの最新レポートによると、世界のCRISPRベースの診断の市場規模は、2025～2030年にかけて16.57％のCAGRを記録し、2030年までに75億5,000万米ドルに達すると予測されています。技術革新はCRISPRベースの診断市場を前進させる上で極めて重要です。Cas12やCas13などの新規Cas酵素の開発により、CRISPRベースの診断検査の感度と特異性が向上しました。これらの進歩により、病原体や遺伝子変異を高い精度で検出できる迅速なポイントオブケア（POC）診断ツールの開発が促進されています。2023年8月、インドのバイオテクノロジー新興企業CrisprBitsは、Molbio Diagnosticsと共同でCRISPRベースのPOC検査を開発しました。この提携は、迅速かつ正確な疾患検出のために設計されたPathCrispプラットフォームの創設につながり、資源が限られた環境におけるCRISPR診断の利用可能性を拡大する上で役立っています。このような共同研究は、技術の進歩がいかに実用的な診断ソリューションに変換されているかを例証しています。

市場規模の急増は、ヘルスケア支出の増加、遺伝子編集技術に対する需要の高まり、慢性疾患や遺伝性疾患の蔓延といった要因によるものです。例えば、世界保健機関（WHO）は2024年に、結核が依然として世界で2番目に多い感染症であり、2023年には推定1,080万人が結核と診断されたと報告しています。このような統計は、CRISPRベースの検査のような高度な診断ツールの差し迫った必要性を強調しています。

遺伝性疾患や感染症の世界の罹患率の増加は、高度な診断ツールに対する需要を増幅させています。国際がん研究機関によると、世界の新規がん患者数は2025年の2,130万人から2050年には3,530万人に増加すると予想されています。同様に、2024年8月にLancet誌に掲載された研究では、非欧州系住民、特にインド亜大陸における嚢胞性線維症の有病率が予想以上に高いことが明らかになりました。このような動向は、CRISPRベース検査のような、様々な疾患の早期発見・治療を可能にする精密かつ迅速な診断法の必要性を強調しています。特定の遺伝子配列を正確に同定するCRISPR診断の能力は、遺伝性疾患や感染症による負担の増大に対処する上で非常に貴重です。

地域的には、CRISPRベースの診断市場は様々な成長パターンを示しています。アジア太平洋は現在最大の市場シェアを占めていますが、これは感染症の高い流行とヘルスケアインフラへの投資の増加によるものです。一方、北米は、研究開発投資の充実と先端診断技術の早期導入により、最も急成長する地域と予測されています。例えば、2023年9月、Sherlock Biosciencesは、ヒトパピローマウイルス（HPV）検出のためのCRISPR技術を活用した迅速で器具を必要としない分子診断法の開発を強化するため、Bill & Melinda Gates Foundationから追加資金提供を受けました。このようなイニシアチブは、公衆衛生の課題解決にCRISPR技術を活用しようとする地域の努力を反映しています。

CRISPRベースの診断市場レポートハイライト

• 2024年、製品別ではキットと試薬が最大の売上シェアで市場を牽引し、CRISPRベースの検出システムが臨床と研究の両方の場面で広く展開されていることがその原動力となっています。ポイントオブケア診断、特に感染症や遺伝病に対する世界的な需要の高まりが、すぐに使える診断キットや高品質の試薬の必要性を高めています。
• 技術別ではCas9が、CRISPR技術開発におけるその基礎的役割により、2024年に圧倒的な市場シェアを確保しました。Cas9はCRISPRに関連する最初のタンパク質として、また最も広く研究されているタンパク質として、正確なDNA標的化と切断を可能にするのに役立っており、遺伝子診断に好ましいツールとなっています。
• 用途別では感染症診断が2024年に最大の市場シェアを占めましたが、これは迅速で正確かつ拡張可能な検査ソリューションに対する世界の緊急ニーズによるものです。CRISPR技術、特にCas12とCas13を活用した技術は、核酸配列を正確に同定することにより、ウイルスや細菌性病原体の高感度検出を可能にします。
• HIV、肝炎、結核、呼吸器感染症など、正確でタイムリーな診断を必要とする感染症の流行が高まっていることが背景にあります。
• 北米は、慢性疾患や感染症の罹患率が高いこと、個別化医療への関心が高まっていること、研究開発支出が多いこと、ポイントオブケア検査が進んでいることなどが要因となって、2024年の世界市場で最大の売上シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 CRISPRベースの診断市場の変数、動向、範囲

• 市場イントロダクション/系統展望
• 市場規模と成長展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• CRISPRベースの診断市場分析ツール
  • ポーター分析
  • PESTEL分析

第4章 CRISPRベースの診断市場：製品別、推定・動向分析

• セグメントダッシュボード
• CRISPRベースの診断市場：製品変動分析、2024年および2030年
• 酵素
• キットと試薬
• ソフトウェアとライブラリ

第5章 CRISPRベースの診断市場：技術別、推定・動向分析

• セグメントダッシュボード
• CRISPRベースの診断市場：技術変動分析、2024年および2030年
• Cas9
• Cas12
• その他

第6章 CRISPRベースの診断市場：用途別、推定・動向分析

• セグメントダッシュボード
• CRISPRベースの診断市場：用途変動分析、2024年および2030年
• 感染症診断
• 遺伝性疾患診断
• がん診断
• その他

第7章 CRISPRベースの診断市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• CRISPRベースの診断市場：最終用途変動分析、2024年および2030年
• 病院・診療所での診断
• 研究所
• 製薬・バイオテクノロジー企業
• その他

第8章 CRISPRベースの診断市場：地域別、推定・動向分析

• CRISPRベースの診断市場シェア：地域別、2024年および2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東およびアフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業分類
• 企業ヒートマップ分析
• 企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Integrated DNA Technologies, Inc.
  • Molbio Diagnostics
  • Horizon Discovery
  • Synthego Corporation
  • Mammoth Biosciences
  • Sherlock Biosciences
  • Caribou Biosciences
  • CrisprBits
  • ToolGen Inc.

List of Tables

• Table 1 List of abbreviation
• Table 2 Global CRISPR-based diagnostics market, by region, 2018 - 2030 (USD Million)
• Table 3 Global CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 4 Global CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 5 Global CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 6 Global CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 7 North America CRISPR-based diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 8 North America CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 9 North America CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 10 North America CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 11 North America CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 12 U.S. CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 13 U.S. CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 14 U.S. CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 15 U.S. CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 16 Canada CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 17 Canada CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 18 Canada CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 19 Canada CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 20 Mexico CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 21 Mexico CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 22 Mexico CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 23 Mexico CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 24 Europe CRISPR-based diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 25 Europe CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 26 Europe CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 27 Europe CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 28 Europe CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 29 UK CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 30 UK CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 31 UK CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 32 UK CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 33 Germany CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 34 Germany CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 35 Germany CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 36 Germany CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 37 France CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 38 France CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 39 France CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 40 France CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 41 Italy CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 42 Italy CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 43 Italy CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 44 Italy CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 45 Spain CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 46 Spain CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 47 Spain CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 48 Spain CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 49 Denmark CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 50 Denmark CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 51 Denmark CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 52 Denmark CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 53 Sweden CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 54 Sweden CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 55 Sweden CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 56 Sweden CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 57 Norway CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 58 Norway CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 59 Norway CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 60 Norway CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific CRISPR-based diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 66 Japan CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 67 Japan CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 68 Japan CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 69 Japan CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 70 China CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 71 China CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 72 China CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 73 China CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 74 India CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 75 India CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 76 India CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 77 India CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 78 Australia CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 79 Australia CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 80 Australia CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 81 Australia CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 82 South Korea CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 83 South Korea CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 84 South Korea CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 85 South Korea CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 86 Thailand CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 87 Thailand CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 88 Thailand CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 89 Thailand CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 90 Latin America CRISPR-based diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 91 Latin America CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 92 Latin America CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 93 Latin America CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 94 Latin America CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 95 Brazil CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 96 Brazil CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 97 Brazil CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 98 Brazil CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 99 Argentina CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 100 Argentina CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 101 Argentina CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 102 Argentina CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 103 MEA CRISPR-based diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 104 MEA CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 105 MEA CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 106 MEA CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 107 MEA CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 108 South Africa CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 109 South Africa CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 110 South Africa CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 111 South Africa CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 112 Saudi Arabia CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 116 UAE CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 117 UAE CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 118 UAE CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 119 UAE CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 120 Kuwait CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 121 Kuwait CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 122 Kuwait CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 123 Kuwait CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 CRISPR-based diagnostics market segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research process
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modelling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market outlook
• Fig. 13 Segment snapshot-1
• Fig. 14 Segment snapshot-2
• Fig. 15 Competitive landscape snapshot
• Fig. 16 Market trends & outlook
• Fig. 17 Porter's five force analysis
• Fig. 18 PESTEL analysis
• Fig. 19 CRISPR-based diagnostics market: Product outlook key takeaways
• Fig. 20 CRISPR-based diagnostics market: Product movement analysis
• Fig. 21 Transfemoral market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Enzymes market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Kits and Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Software and libraries market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 CRISPR-based diagnostics market: Technology outlook key takeaways
• Fig. 26 CRISPR-based diagnostics market: Technology movement analysis
• Fig. 27 Cas9 market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Cas12 market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 CRISPR-based diagnostics market: Application outlook key takeaways
• Fig. 31 CRISPR-based diagnostics market: Application movement analysis
• Fig. 32 Infectious disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Genetic disorder diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 CRISPR-based diagnostics market: End-use outlook key takeaways
• Fig. 37 CRISPR-based diagnostics market: End-use movement analysis
• Fig. 38 Hospitals and clinics diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Pharmaceutical and biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Regional marketplace outlook, 2024 & 2030 (USD Million)
• Fig. 43 Regional marketplace: Key takeaways
• Fig. 44 North America CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Key country dynamics
• Fig. 46 U.S. CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Key country dynamics
• Fig. 48 Canada CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Key country dynamics
• Fig. 50 Mexico CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Europe CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Key country dynamics
• Fig. 53 UK CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Key country dynamics
• Fig. 55 Germany CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Key country dynamics
• Fig. 57 France CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 Spain CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 Italy CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Key country dynamics
• Fig. 63 Denmark CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 Sweden CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Key country dynamics
• Fig. 67 Norway CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Asia Pacific CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 Japan CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 China CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Key country dynamics
• Fig. 74 India CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Key country dynamics
• Fig. 76 Australia CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Key country dynamics
• Fig. 78 South Korea CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Key country dynamics
• Fig. 80 Thailand CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Key country dynamics
• Fig. 82 Market participant categorization
• Fig. 83 CRISPR-based diagnostics market position analysis, 2024
• Fig. 84 Strategic framework

CRISPR-based Diagnostics Market Growth & Trends:

The global CRISPR-based diagnostics market size is expected to reach USD 7.55 billion by 2030, registering a CAGR of 16.57% from 2025 to 2030, according to a new report by Grand View Research, Inc. Technological innovations have been pivotal in propelling the CRISPR diagnostics market forward. The development of novel Cas enzymes, such as Cas12 and Cas13, has enhanced the sensitivity and specificity of CRISPR-based diagnostic tests. These advancements have facilitated the creation of rapid, point-of-care (POC) diagnostic tools capable of detecting pathogens and genetic mutations with high accuracy. In August 2023, Indian biotech startup CrisprBits collaborated with Molbio Diagnostics to develop CRISPR-based POC tests. This partnership led to the creation of the PathCrisp platform, designed for rapid and precise disease detection, and has been instrumental in expanding the availability of CRISPR diagnostics in resource-limited settings. Such collaborations exemplify how technological advancements are translating into practical diagnostic solutions.

The surge in market size is attributed to factors such as increased healthcare spending, heightened demand for gene editing technologies, and a growing prevalence of chronic and genetic diseases. For instance, the World Health Organization reported in 2024 that tuberculosis (TB) remained the second most common infectious disease worldwide, with an estimated 10.8 million people diagnosed in 2023 Such statistics underscore the pressing need for advanced diagnostic tools such as CRISPR-based tests.

The increasing incidence of genetic disorders and infectious diseases globally has amplified the demand for advanced diagnostic tools. According to the International Agency for Research on Cancer, the number of new cancer cases worldwide is expected to rise from 21.3 million in 2025 to 35.3 million by 2050. Similarly, research published in The Lancet in August 2024 highlighted a higher-than-expected prevalence of cystic fibrosis in non-European populations, particularly in the Indian subcontinent. These trends underscore the necessity for precise and rapid diagnostic methods, such as CRISPR-based tests, which can facilitate early detection and treatment of various diseases. The ability of CRISPR diagnostics to accurately identify specific genetic sequences makes them invaluable in managing the growing burden of genetic and infectious diseases.

Geographically, the CRISPR diagnostics market exhibits varying growth patterns. Asia Pacific currently holds the largest market share, driven by a high prevalence of infectious diseases and increasing investments in healthcare infrastructure. Conversely, North America is projected to be the fastest-growing region, attributed to substantial research and development investments and early adoption of advanced diagnostic technologies. For instance, in September 2023, Sherlock Biosciences received additional funding from the Bill & Melinda Gates Foundation to enhance the development of rapid, instrument-free molecular diagnostics leveraging CRISPR technology for Human Papillomavirus (HPV) detection . Such initiatives reflect the regional efforts to harness CRISPR technology in addressing public health challenges.

CRISPR-based Diagnostics Market Report Highlights:

• In 2024, kits and reagents led the market with a largest revenue share, driven by the widespread deployment of CRISPR-based detection systems in both clinical and research settings. The increasing global demand for point-of-care diagnostics, particularly for infectious and genetic diseases, has amplified the need for ready-to-use diagnostic kits and high-quality reagents.
• The Cas9 segment secured the dominant market share in 2024, due to its foundational role in the development of CRISPR technologies. As the first and most widely studied CRISPR-associated protein, Cas9 has been instrumental in enabling precise DNA targeting and cleavage, making it a preferred tool for genetic diagnostics
• The infectious disease diagnostics held the largest market share in 2024, driven by the urgent global need for rapid, accurate, and scalable testing solutions. CRISPR technologies, particularly those leveraging Cas12 and Cas13, enable highly sensitive detection of viral and bacterial pathogens by identifying nucleic acid sequences with precision.
• Pharmaceutical and biotechnology companies held the dominant market share in 2024 and is expected to be the fastest-growing segment over the forecast period. driven by the rising prevalence of infectious diseases such as HIV, hepatitis, tuberculosis, and respiratory infections, which require accurate and timely diagnosis.
• North America dominated the global market with the largest revenue share in 2024, driven by a high burden of chronic and infectious diseases, a growing focus on personalized medicine, substantial R&D spending, and advances in point-of-care testing.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. CRISPR-Based Diagnostics Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. CRISPR-Based Diagnostics Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. CRISPR-Based Diagnostics Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. CRISPR-Based Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million)
• 4.3. Enzymes
  • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Kits and Reagents
  • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Software and Libraries
  • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. CRISPR-Based Diagnostics Market: Technology Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. CRISPR-Based Diagnostics Market: Technology Movement Analysis, USD Million, 2024 & 2030
• 5.3. Cas9
  • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Cas12
  • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Others
  • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. CRISPR-Based Diagnostics Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. CRISPR-Based Diagnostics Market: Application Movement Analysis, USD Million, 2024 & 2030
• 6.3. Infectious Disease Diagnostics
  • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Genetic Disorder Diagnostics
  • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Cancer Diagnostics
  • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. CRISPR-Based Diagnostics Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. CRISPR-Based Diagnostics Market: End Use Movement Analysis, USD Million, 2024 & 2030
• 7.3. Hospitals and Clinics Diagnostic
  • 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Laboratories
  • 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Pharmaceutical and Biotechnology Companies
  • 7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. CRISPR-Based Diagnostics Market: Regional Estimates & Trend Analysis

• 8.1. CRISPR-Based Diagnostics Market Share, By Region, 2024 & 2030 ( USD Million)
• 8.2. North America
  • 8.2.1. North America CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.2.2. U.S.
    • 8.2.2.1. U.S. CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.2.3. Canada
    • 8.2.3.1. Canada CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.2.4. Mexico
    • 8.2.4.1. Mexico CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.3. Europe
  • 8.3.1. Europe CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. UK
    • 8.3.2.1. UK CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Germany
    • 8.3.3.1. Germany CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.4. France
    • 8.3.4.1. France CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.5. Italy
    • 8.3.5.1. Italy CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.6. Spain
    • 8.3.6.1. Spain CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.7. Denmark
    • 8.3.7.1. Denmark CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.8. Sweden
    • 8.3.8.1. Sweden CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.9. Norway
    • 8.3.9.1. Norway CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.4. Asia Pacific
  • 8.4.1. Asia Pacific CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. Japan
    • 8.4.2.1. Japan CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. China
    • 8.4.3.1. China CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. India
    • 8.4.4.1. India CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. Australia
    • 8.4.5.1. Australia CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.6. South Korea
    • 8.4.6.1. South Korea CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.7. Thailand
    • 8.4.7.1. Thailand CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Latin America
  • 8.5.1. Latin America CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Brazil
    • 8.5.2.1. Brazil CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Argentina
    • 8.5.3.1. Argentina CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Middle East and Africa
  • 8.6.1. Middle East and Africa CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. South Africa
    • 8.6.2.1. South Africa CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Saudi Arabia
    • 8.6.3.1. South Africa CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. UAE
    • 8.6.4.1. UAE CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Kuwait
    • 8.6.5.1. Kuwait CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis by Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Heat Map Analysis
• 9.4. Company Profiles
  • 9.4.1. Thermo Fisher Scientific Inc.
    • 9.4.1.1. Participant's Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Recent Developments/ Strategic Initiatives
  • 9.4.2. Integrated DNA Technologies, Inc.
    • 9.4.2.1. Participant's Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Recent Developments/ Strategic Initiatives
  • 9.4.3. Molbio Diagnostics
    • 9.4.3.1. Participant's Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Recent Developments/ Strategic Initiatives
  • 9.4.4. Horizon Discovery
    • 9.4.4.1. Participant's Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Recent Developments/ Strategic Initiatives
  • 9.4.5. Synthego Corporation
    • 9.4.5.1. Participant's Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Recent Developments/ Strategic Initiatives
  • 9.4.6. Mammoth Biosciences
    • 9.4.6.1. Participant's Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Recent Developments/ Strategic Initiatives
  • 9.4.7. Sherlock Biosciences
    • 9.4.7.1. Participant's Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Recent Developments/ Strategic Initiatives
  • 9.4.8. Caribou Biosciences
    • 9.4.8.1. Participant's Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Recent Developments/ Strategic Initiatives
  • 9.4.9. CrisprBits
    • 9.4.9.1. Participant's Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Recent Developments/ Strategic Initiatives
  • 9.4.10. ToolGen Inc.
    • 9.4.10.1. Participant's Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Recent Developments/ Strategic Initiatives